Your start-up is working on an innovative Digital Health, Healthtech, Biotech or Medtech product or service, and you’re ready to get your business moving forward? Then find out more about our offers, current tenders, trainings, pitches and awards especially for start-ups, scaleups, spin-offs and SMEs.
“The SHIP event really got us excited, especially the inspirational environment for innovation and the extensive networking opportunities. The feedback from the jury was a great help to further improve and sharpen our strategy.”
“For startups in the ‘early stage’, a strong network that connects with the right people and institutions is critical. Not only did EIT Health provide us with valuable strategic input with the SHIP event for our business development, but we also networked with those who helped us in a pivotal phase. “
“EIT Health has a really great concept for startups. Through our participation and 1st place in the Headstart Programme and the European Health Catapult, we not only generated high visibility for our business, but also gained direct access to investors and further coaching. I think every healthcare startup can only benefit from the EIT Health network. “
“We have been welcomed in the EIT Health Community with open arms and love the energy in this network! It is overwhelming to see what efforts are being made in the organization of the projects and programmes, and we are very glad to be part of it ! Keep up the good work! “
“We believe the EIT Health Community is a unique environment for the best possible connectivity and growth, and all contact opportunities can lead to important partnerships and new milestones for any startup. We encourage everyone to be more involved and open to new opportunities.”
“We are now conducting further discussions with UCB. The discussions and the training of the programme were of very high quality. We have learned and improved a lot and have definitely changed our view of our own business and the strategy we want to follow.”
“We had a very interesting conversation with Ferrer. They really want to dive deeply into the motor symptoms of Parkinson’s patients, and we’ll band together at short notice and see what we can do with our gait analysis system for their products.”
“We had good talks not only with high-ranking pharmaceutical representatives, but also with experts with extensive specialists and industry expertise! I would like to mention in particular our very helpful exchange with the EIT Health Team and the close cooperation with our mentor from the EIT Health Mentoring & Coaching Network. “
To meet the future challenges of European healthcare, EIT Health’s Accelerator programmes and projects create a favorable environment for innovation and provide you with skills and services to bring innovative business ideas to market at every stage of your business.
Advitos has developed a completely new multi-organ support therapy through their product, ADVOS System, the world’s first method of personalized support for the body’s three main detoxification organs: the liver, lungs, and kidneys.
Advosense is developing the next generation of incontinence care products, to empower clinicians to know when, where and how best to respond to their patients’ needs.
Amparo’s vision is to empower 90% of the world’s 30 million amputees, giving them access to affordable, high-quality prosthetics. Amparo’s revolutionary prosthetic socket solution is the fastest, easiest and most affordable on the market.
Intrepida provides Ancora.ai, an AI-powered online platform that helps patients and health volunteers search for and connect with clinical trials for COVID-19 diagnostics, treatments and vaccines.
Ares Genetics aims to revolutionise infectious disease diagnostics and therapeutics by developing novel approaches to improve the rapid detection of antibiotic resistance in patients with microbial infections as well as tools to accelerate antibiotic research.
ArtiQ developed AI-based software to help doctors save their time and improve accuracy when diagnosing lung diseases.
AUCTEQ, the Winner of the the ‘Headstart Award’ 2019, AUCTEQ Biosystems, is developing a growing bioreactor for cell cultures in biopharmaceutical production, combining the safety of the cells with user-friendliness and cost-efficiency to create a modern and sustainable cell culture process.
Aumio is the digital companion for children’s mental health.
MedKitDoc® connects doctors, certified medical devices and patients in a way that may be characterized as revolutionary for telemedicine. We enable telemedicine 2.0 for diagnosis of complex diseases by integrating digital connected health devices with specially trained physicians.
BestHealth4u is specialised in developing novel medical adhesive solutions. Their product, Bio2Skin, is a revolutionary nano-based adhesive for medical applications that can be integrated into a wide range of medical devices.
Bicoll provides an efficient, multi-disciplinary approach to drug discovery, based on molecules from plant extracts. Their Bicoll Plant Profiles provide access to the most promising source of new patentable, high quality leads in 9 months at a reasonable cost.
BioXplor Oncology AI is an intelligent state-of-the-art NLP-knowledge discovery and AI-drug discovery platform for Oncology.
BOCAhealth improves the quality of life and reduces the mortality of chronically and acute ill patients via optimal fluid management by using innovative sensors and AI technology. The project is focused on diseases related to hydration and nutrition problems.
Breathment is a digital physiotherapist that instructs and gives live-feedback to lung patient’s breathing exercises which enables lung physiotherapists to enhance and control their treatment without presence.
Despite its ubiquitous use, X-ray imaging causes health concerns due to the large dose of ionizing radiation that patients receive. For example, 2% of cancers are caused by X-ray exposure. Additionally, X-ray imaging detector systems are associated with high costs and poor resolution for low-cost models. We are developing a novel perovskite quantum dot-based scintillator that greatly increases detector sensitivity and resolution. The low cost of such scintillators would tremendously extend the benefits of high resolution / low dose X-ray imaging to all patients and make an EU company the market leader in X-ray scintillator design and fabrication.
Carbomed Medical Solutions is extending its CO2 measurement technology to provide support in detection and monitoring of Portable Interstitial Lung Disease (ILD) for SMP 2020.
CardiLink’s cloud-based software platform enables remote monitoring of Automated External Defibrillator devices, providing owners and manufacturers with critical insights into the operational effectiveness of their devices.
Predictive cardiac analytics cloud platform of completest cardiac signal processing and analysis to automate electrocardiogram interpretation for doctors and serve greater longevity of patients.
Cievert uses technology to optimise post-discharge pathways by automatically monitoring patients, stratifying risk and providing personalised information.
Climedo is a 2017 Headstart winner, which is empowering healthcare professionals by providing an intelligent platform for digitally connected medical research where all research-relevant data and information is stored in a structured manner. As a result, hospitals can gain more efficiency, patient safety and data-driven decision support.
Coldplasmatech developed a new wound dressing that creates cold plasma directly on the damaged skin, destroying multiresistant bacteria and stimulating the body’s self-healing powers.
Collaborate Health Cloud is a modern patient management & collaboration tool, re-designed from scratch to help doctors reduce errors and increase patient compliance to medical plans by facilitating diagnostic and communication tasks, particularly of those related to team-based diagnosis, error-detection and patient follow up.
Cyntegrity offers a specialised cloud software for GCP compliant Risk-Based Monitoring (RBM).
Deepc is a health diagnostics startup, on a mission to eliminate medical errors and save human lives using AI. Their cutting-edge deep learning technology is transforming medical diagnostics by processing large-scale medical data in real-time and automatically detecting pathologies, thus supporting physicians in making life-saving diagnostics.
DeepCare provides employees with a digital physiotherapist in the form of a smart assistant device at their desk. It tracks their upper body, uses its AI-brain to analyze their behavior, and offers individualized guidance for healthier behavior.
As a result, the sitting behavior, health and vitality of office employees are sustainably improved.
DeepSpin is developing a next-gen, AI-powered MRI imaging machine at a fraction of the cost, size and weight of standard systems
Dermus is developing a cost-effective, portable scanning device providing information about the whole layer of skin. By seeing the whole picture, it enables early skin cancer detection and skin cancer treatment planning, enabling healthcare providers and patients to get a diagnosis that is accessible, accurate and timely.
DigniSens is dedicated to the development of a smart sensoric system for people affected by incontinence. The sensor is designed to be applied on diapers for detecting fecal incontinence in elderly, which in case of bowel movement, it automatically sends a notification to nursing staff or other support care providers.
DITG is a leading innovator in the development of patient management programmes with evidence-based curative outcomes for chronic conditions, focusing on digital and telemedical solutions.
Dust Biosolutions is involved in the development and production of innovative biological adhesives for applications within the mining, infrastructure, construction, and agriculture industry. Their first product: a customized solution to control dust more cost-efficiently and environmentally friendly.
Earlysight invented a cellular-level imaging modality with unprecedented contrast to detect minor structural changes of the retina in only few seconds. The EPFL spinoff help s understand the origins of many diseases such as age-related macular degeneration and provide quantitative metrics for therapeutic endpoints.
EnFin GmbH is the world-wide only manufacturer of ready-to-use enzymatic Test Kits for detection of fast growing aerotolerant anaerobic (mammalian) cells.
As spin-out of the Biomedical Center Munich EisbachBio develops novel medicines that target chromatin regulatory mechanisms essential to tumors. Thanks to a unique screening approach, Eisbach will establish cures for tumors that currently have no viable therapeutic option.
eMurmur is a digital health company specializing in Machine Learning for the analysis of data for medical applications. The company is the leader in automated heart murmur detection technology, demonstrating expert-level accuracy rates for its flagship solution eMurmur ID (FDA cleared, CE marked).
Endometriosis is a diverse disease with varying symptoms. The App provides patients with facts on endometriosis, gives the opportunity to montor the symptoms and helps with finding the right therapy.
Eukarÿs synthetic non-viral gene therapy, the most advanced treatment of which enters the regulatory preclinical phase, is designed to resolve the main obstacles that gene therapy must face, in particular safety, tolerance, efficacy, vectorization immunogenicity and production costs.
FeelSpace is an intelligent vibration navigation system for blind and visually impaired people to orient themselves in a foreign environment. Designed as a tactile compass belt, FeelSpace uses vibrational signals to indicate directions to the wearer.
Flowbone is a new generation of injectable biomaterial for a quick and subtle, local strengthening of fragile bones.
GeoHealthApp is a mobile app which determines the individual risk of infection using the location function.
GP4R is a spin-off of the Medical University of Gdańsk, which is developing a platform to link general practitioners to clinical trials, therefore facilitating clinical trials enrolment.
The ideas behind Hearable Labs is to implement augmented hearing algorithms on miniaturized electronics, to give everyone control over what they hear. The hardware startup is developing the technology for noise-cancelling earbuds, which would enable full control over the auditory environment.
Hemotune AG is developing a revolutionary medical device for blood purification that combines cutting-edge scientific results from biomedicine and nanotechnology, allowing specific and direct removal of disease-causing substances from the blood stream of a patient.
Heyfair is the developer of SteriCoach, a temporarily colored hand disinfectant for the prevention of infections that indicates which parts of the hands are disinfected and which are not.
HumanITcare is an AI digital platform for the follow-up of patients that are under medical treatment with the main purpose of helping physicians to provide better and faster clinical decisions with real-life patient outcomes, which are collected from the patients’ devices and the passive sensors.
InContAlert is a wearable sensor system for non-invasive measurement of the filling level of the urinary bladder. The device helps incontinence patients to conveniently receive an alert when a predefined filling level is reached. inContAlert thereby minimizes the risk of an uncontrolled loss of urine and allows for living a normal and jaunty life.
Inveox develops systems for the digitisation, automation and networking of pathology laboratories, increasing the safety and reliability of cancer diagnoses, and the efficiency and profitability of laboratories.
Ionera provides a universal chip platform for ion-conductance based analytics, used for development and customization of multielectrode cavity array (MECA) chips, nanopore and channel protein reconstitution kits and assays.
IPDx is developing a saliva-based point of care test to diagnose ILDs.
IQ Medworks is a successful service provider for intelligent solutions in the healthcare sector.
Iuvando Health is a patient-centric digital health solution for cancer patients who seek to benefit from investigational treatments as offered in clinical trials.
One Surgery is the company behind iSurgeon, an augmented reality-based product used to train surgeons for minimally invasive surgery.
Kazaam Lab S.R.L.: Fill the gap between data and Precision Medicine through decision support based on Big Data Analytics, Artificial Intelligence and Microservices Software Architectures, bringing to light hidden information from genotype-phenotype data by the analysis of molecular interactions.
As spin-off of the Technical University of Munich Kumovis develops 3D-printing systems for medical applications, designed to manufacture a high variety of medical products starting from prototyping up to personalized human implants. Their first product, R1 3D printing system is already commercially available.
Lab on fiber is specialized in the development, commercialization and production of innovative fiber delivery and laser systems to improve outcomes of laser surgery and patient safety.
LaraLab offers full-fledged solution from data processing to automatized analysis based on artificial intelligence, in order to increase patient security and efficiency of latest cardiovascular therapies.
LenioBio is a protein expression platform company committed to the advancement of transformative technology for the discovery, development, and large-scale production of proteins, unconstrained by the limitations of the cell.
LifeTime offers a decentralized infrastructure for end-to-end encrypted data exchange with which healthcare facilities could send and receive digital patient data.
Living Brain uses their experience to focus their Virtual Reality based cognitive training, their medical software and their knowledge to help millions of people worldwide to achieve a more fulfilled and happier life for patients, decreased recovery time and support research companies gaining new insights in neuro-rehabilitation.
The biopharma startup Lumobiotics is developing anti-cancer & anti-microbial photocontrollable peptidomimetics with their proprietary ON | OFF bioactivity switch to enhance efficacy and safety.
Lymphatica medtech: The world´s first implantable device for lymphedema treatment.
Mecasa currently develops the first European matching platform for live-in caregiving: a place where seniors in need of support will be matched with loving and qualified caregivers based on individual character traits of the two people involved.
The spin-off from RWTH Aachen University develops metallic bioabsorbable implants for orthopedic and traumatic surgery. A European Health Catapult finalist, Medical Magnesium eliminates the need to remove orthopedic implants after surgery, as they are physiologically degradable after fracture healing.
Medical Templates develops medical devices for interventional radiology and minimal invasive surgery. Their product, Puncture cube, navigates needles used in CT guided punctures, combining an intelligent planning software with a single use, sterile guidance device.
MetaHeps is working on a diagnostic test to diagnose or to exclude drug-induced liver injury, using patient-specific cells, which are produced by means of a patented procedure from a blood sample.
Midaia develops solutions for predicting the best individual treatment for patients with rheumatic diseases, consisting of a smartphone app for patients, and disease assessment and decision-support software for clinicians.
Mindpax is dedicated to the monitoring and improvement of mental and physical well-being. The startup is developing a medical device, which collects long-term data on patients’ patterns of sleep, activity and behaviour and functions as an early warning system for people with depression, bipolar disorder or schizophrenia.
Moio Care is developing a comprehensive technical support device in the nursing care, a smart care patch. Worn directly on the skin by people in need of care, it automatically collects and interprets sensor information and informs caregivers as soon as there is a concrete need for action via a smartphone app.
MR Shim is revolutionizing MRI diagnostic quality through a Plug&Play device based on AI to improve the quality of images by removing noise, background and movement of the patients.
MukoCell GmbH has developed the first tissue engineered product and technology, MukoCell, a laboratory-made tissue transplant of oral mucosa cells for the reconstruction of human tissue, bringing advanced therapy medicine in urology on the market.
Munevo is simplifying the everyday life of people with physical disabilities with their Smartglass application that detects head movements and voice commands and then translates these into control signals for the wheelchair.
My Life Technologies is developing a unique technology based on ceramic nanoporous MicroNeedle Arrays (npMNA), which allow to locally deliver antibacterial and antifungal drugs.
Nanoleq is developing a new cable technology. Based on a smart layer arrangement of the cable and the use of innovative stretchable and conductive materials, Nanoleq’s electric cables are 100-times more resistant to mechanical wear and tear.
NeuroDigital1 enables instant access to prognostic and preventive brain health care (cognitive ability and mental health) powered by AI.
NevisQ has developed a smart sensor system, which allows discreet room activity analysis. The solution is envisioned to be implemented in healthcare facilities, supporting caregivers by detecting falls or deviations in the personal routine of a resident.
Nia Health develops and markets a service platform for patients with skin diseases. The core product is a smartphone app, which supports patients and their relatives in their daily dealings with atopic dermatitis
Niucare‘s product is HealthConnect, a decentralized patient network that provides healthcare providers with secure, interoperable, independent access to individual patient data.
Nubedian GmbH offers solutions for healthcare and social economies based on cloud computing and mobile software technologies.
OHDA is a professional medical information management platform offering services such as instant medical help, doctors and treatment abroad and more.
Oncgnostics specialises in the development of in vitro diagnostic tests for all areas of cancer diagnostics. Their tests are based on epigenetic changes, so-called DNA methylations, which are characteristic for cancer cells. These highly informative biomarkers, validated and patented by oncgnostics, represent the core of their products and provide the basis for their activities.
Opto biolabs develops smart illumination devices combining optogenetics with flow cytometry and cell sorting for the first time.
Ormosys is an innovative product in the field of orthopedic insole care. Its Orthopedic Module Insole System is a holistic dynamic body analysis system, combining human gait analysis and other holistic and dynamic measurements.
Parsek Information Technologies GmbH has developed a digital platform to connect different stakeholders of healthcare.
PerAGraft aims to develop and produce patient individualized implants for cardiovascular applications.
PhagoMed Biopharma is a biotech company focused on the development of innovative, phage-based treatments against persistent bacterial infections and microbiome dysbiosis.
PharmGenomics develops novel tests for clinical diagnostics in the field of pharmacogenetics and individualized medicine, based on a novel macroarray technology.
The EPFL spin-off Piemacs won the Headstart Grant in 2017 for its idea to use a piezoelectric MEMS (Micro Electro Mechanical Systems) transducer for a new type of hearing aid, or what they call “contact lens for the ear“.
Piomic develops an innovative medical device for the treatment of hard-to-heal wounds.
Pilloxa has developed a platform that consists of an intelligent pillbox, an app and a cloud solution, along with data-driven services, facilitating medication adherence. The patient-centric adherence platform is teaming up with Bayer AB to further develop digital treatment aids that empower the patient and improve the result “beyond the pill”.
Portabiles HealthCare Technologies is developing a mobile sensor system for medical gait analysis, Mobile GaitLab. Placed inside a shoe, Mobile GaitLab is designed to be worn continuously and inconspicuously in everyday life by patients with chronic movement disorders.
Proteona is using single cell proteogenomics to build a database of multiple myeloma tumor responses to various therapies and then mining that database with proprietary AI tools to identify the best treatment option for new cancer patients.
Qapsula is a virtual personal assistant, which helps people manage their health, by controlling their health status, providing personal medical recommendations and by connecting them with doctors from a full range of available specializations.
Qolware is the company behind Lola app, the first digital solution developed for commercial smartphones and smartwatches that provides a continuous health and emergency assistance in everyday life and supports you in daily planning.
QraGo developed the UBER for our healthcare system.
RAMPmedical is an EU awarded AI decision support tool that helps doctors to find the right treatment for their patients. Wrong therapy is a major problem in healthcare. According to the WHO, one in ten patients receives the wrong treatment, resulting in unnecessary suffering and often death. Already covering endocrinological and cardiological treatments, the software matches patient data with evidence and treatment guidelines, leaving the final decision with the fully informed and AI-empowered doctor.
Real Research Sp. z o.o.: In vitro screening of potential chemotherapeutics in patient cells grown in 3D on LifeGel to choose the right treatment in one week.
ReMeDi is a provider of unique solutions for the healthcare environment, combining leading edge technology and unique designs to deliver an excellent healthcare platform solution.
SanoLiBio is developing a fully automated circulating tumor cell (CTC) enrichment platform, called “Walderbach”, as a new benchmark in rare cell isolation from 2020 onwards internationally, enabling early stage cancer diagnostic in a fast, reliable and affordable way for the very first time.
Scarletred Holding GmbH: The expert in objective skin monitoring, skin image analysis and telemedicine
ScintHealth develops the first minimally invasive software-based curative therapy for spinal cancer.
Covid-19: ScintHealth is working on minimising the spread of contagious diseases in healthcare facilities, using smart, ultraviolet C systems that reliably and quickly inactivate germs, including the coronavirus, thereby preventing harm to humans.
EPFL spin-off Sensars Neuroprosthetics is one of the winners of the EIT Health Germany Headstart Award, which developed a bionic prosthesis, SENSY, that has the ability to restore touch and movement sensations from the prosthesis of leg amputees by nerve stimulation.
Simfo GmbH is a research and development facility that has achieved the top levels of expertise in personalised medicine. It focuses particularly on the development of innovative analysis methods in oncological diagnostics in order to optimise patient-specific therapy.
SiTools Biotech designs and produces advanced genetic tools: siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion.
Sleepiz offers a secure non-contact multidimensional sleep monitoring and assessment solution, hoping to accelerate sleep disorder diagnosis.
Smart4Diagnostics closes the preanalytical data gap between blood collection and lab analysis and enables a new quality standard for diagnostic decision making.
SpinDiag produces a diagnostics platform for on-site use, enabling the rapid and reliable screening of patients for antibiotic-resistant germs at hospital admission.
Synoia Technologies specializes in developing a product integrating multiple technologies together with treatment capsules for diabetic skin condition.
TherapySelect is focused on the development, clinical validation and sale of diagnostic tests for cancer patients. Their product Chemotherapy Resistance Test is an in vitro chemo resistance test on living tumour cells.
Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology, expanding the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients.
Virtonomy is creating the first cloud-based SaaS solution for use by medical device developers that utilizes virtual patients for data-driven clinical trials, thereby shortening the time-to-market for life-essential medical devices, accelerating medical innovation, and significantly reducing costs.
The Smart Seat Cushion for seniors from VISSEIRO measures and analyzes vital data – without any skin contact.
Volumina Medical is active in the field of tissue engineering and develops injectable 3D scaffolds for the reconstruction of volumes of soft tissues that have been lost after tumor ablation, disease, trauma, or for purely esthetically purposes.
By using DNA nanotechnology, Waldo Diagnostics aim to develop diagnostic assays based on the direct detection of single target molecules that can be visualized with low-tech detection devices such as smartphone cameras.
Walkolution GmbH has developed the world´s first noiseless and non-electric walking treadmill.
Zendra Health wants to improve people’s lives and accelerate research into chronic conditions their platform that enables healthcare professionals to build evidence-based Digital Health solutions in just a few clicks and at a fraction of the cost.
Zoundream applies the latest developments of artificial intelligence and sound recognition to the very specific field of new-borns cry – in order to translate baby cries sounds into their needs, emotions and physical status.